On April 16, 2025, NovaBay Pharmaceuticals' stockholders approved the liquidation and dissolution of the Company with 3,080,743 votes in favor, while also granting the Board authority to adjourn the meeting if needed. Approximately 54% of shares were represented at the meeting.